Jun 01 2018
Auris Health made the coveted CNBC Disruptor 50 List for 2018, making it one of the few healthcare companies to receive the honor. Each year CNBC features private companies of all types whose game-changing innovations are transforming how the world does business. Joining the ranks of Airbnb, Lyft, and SpaceX, Auris was honored for the innovative work it brings to bronchoscopic procedures with its Monarch Platform. The goal of Auris’s robotic technology is to enable more accurate diagnosis, and eventually treatment, of small and hard-to-reach nodules in the periphery of the lung.
May 15 2018
Auris announced its collaboration with NeuWave Medical, a subsidiary of Ethicon, Inc. and part of the Johnson & Johnson Medical Devices Companies this week. The goal is to enable robotically assisted bronchoscopic ablation of lesions in the lung. This cooperative development and commercialization agreement calls for a co-development of integrated systems for robotic control, navigation and application of microwave ablation delivered via bronchoscopes.
Apr 27 2018
The Monarch Platform made headlines for the first use of the technology at El Camino Hospital, located in Mountain View, California, as part of a clinical trial. El Camino’s clinical trial marks the first institution in the United States to use the Monarch Platform’s robotic technology for bronchoscopic procedures. Dr. Ganesh Krishna, the pulmonologist who performed the first case on March 30, 2018, believes the Monarch Platform marks a needed “paradigm shift” in the way physicians diagnose lung disease.
Apr 12 2018
Auris Health is featured for its innovative technology and its co-founder, Dr. Fred Moll, who helped pioneer Auris’s beginnings. Dr. Moll, a serial entrepreneur and surgical robotics visionary, references in the article the growing need for more precise, capable hands in minimally invasive surgeries.
Apr 12 2018
El Camino Hospital, located in Mountain View, California, reported that its interventional pulmonology team successfully used the Monarch Platform, a robotic bronchoscope system, as part of a clinical trial. This marks the first procedure of its kind in the US. Dr. Ganesh Krishna, medical director of the Interventional Pulmonology Program at El Camino Hospital, summarizes his use and belief in Auris’s technology.
Apr 03 2018
The recent FDA clearance for Auris Health, formerly known as Auris Surgical Robotics, brings to light the immense opportunity for the surgical robotics market as it continues to grow. According to the article, the competition is growing, and the global surgical robotics market could reach $12.6 billion by 2025. The article also highlights the importance of collaboration between the robotics companies and hospitals to allow for full adoption of surgical robots.
Apr 03 2018
In the wake of Auris receiving FDA clearance for its Monarch Platform, the innovative robotic technology is catching the attention of many. According to Surgical Products Magazine, the Monarch Platform’s approach to flexible technology with its application in bronchoscopy could be a game-changer. The article also mentions reasons why Auris Health CEO, Dr. Fred Moll, believes the technology has the potential to transform the treatment of lung cancer.
Mar 29 2018
With the introduction of the Monarch Platform, Auris will leverage the power of flexible robotics to transform endoscopy, the use of small cameras and tools to enter the body through its natural openings. With bronchoscopy as its first application, the Monarch Platform could help physicians reach into the periphery of the lungs. This capability would give the physician access to lung nodules that can often times be missed. According to the article, the potential for Auris’s technology could include delivery of therapy in addition to helping with diagnosis.
Mar 26 2018
Business Insider features Auris’s animation of its Monarch Platform during a bronchoscopy procedure. The article also notes that the Monarch Platform integrates the latest advancements in robotics, software, data science, and endoscope innovation. The goal of the Monarch Platform is to dramatically improve patient outcomes, enhance physician capabilities, and lower costs to the healthcare system.
Mar 25 2018
Auris is featured in this TechCrunch article for the reveal of its robotic endoscopic technology called the Monarch Platform. With the use of the Monarch Platform’s flexible robotics and controller, a physician can navigate to hard-to-reach places in the periphery of the lung.